Life Science

Take two of these and call me in the morning

The pharmaceutical industry has been taking a shellacking lately. Industry leaders complain like Rodney Dangerfields: They don’t get no respect, no respect at all.

Read More »

Nano Killers Aim at Mini Tumors

Nano Killers Aim at Mini Tumors And you though nano-technology was the stuff of science fiction. A company called Kereos is developing a pair of nanotechnologies to identify tumors that measure just 1 mm in diameter, then kill them with a tiny but precise amount of a chemotherapy drug. Even our own Robert Smith, the director of cancer screening is ...

Read More »

Catching Up: What about BIO 2004?

I’m just getting back to BIO 2004. There were two things that struck me about this particular meeting:

Read More »

Cancer Drugs Aim at More Targets

Cancer Drugs Aim at More Targets Good article from Wired on the new cancer drugs coming to market soon. “These drugs represent the next generation of anti-angiogenesis drugs beyond Avastin,” said William Li, president and medical director of the Angiogenesis Foundation, a non-profit institution based in Cambridge, Massachusetts. “If chemotherapy is like a dirty bomb and Avastin like a smart ...

Read More »